Dynamic survival models can be used to predict long-term survival in health technology assessment by extrapolating survival curves beyond the observed data. A simulation study compared different dynamic survival models with and without a cured fraction when extrapolating data from a curative treatment with 25% cured. Dynamic survival models that included a cured fraction performed better than those that did not. The models can also incorporate general population mortality to create dynamic relative survival models. Applying these to a case study showed they can impact cost-effectiveness results and sensitivity analyses compared to the company and evidence review group extrapolations.